MRNA
Moderna·NASDAQ
--
--(--)
--
--(--)
4.54 / 10
Netural
Fund flow analysis scores 7.87/10, indicating robust fund flow characteristics. Bullish trends in Small and Large contrast with bearish signals in overall, block, Medium, and Extra-large, suggesting positive liquidity momentum. Research analyst consensus shows divided analyst consensus, demonstrating neutral perspective. Current ratings: Neutral(100.0%) across 1 coverage providers, supported by 1.21 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-07
InstitutionUBS
Times predicted4
Historical Win Rate25.0%
Is money flowing into or out of MRNA?
- MRNA holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.54/10 (Netural).
